{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/neurocrine-biosciences-announces-initiation-of-phase-1-clinical-study-evaluating-nbip-1968-a-glp-1gipglucagon-receptor-triple-agonist-302845522.html", "message": "News view counter 869538 successfully enlarged"}